Compare SiTime Corporation (SITM) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SiTime Corporation vs TransMedics Group Inc — how do they compare? SiTime Corporation trades at $600 (market cap $16.63B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: SiTime Corporation is far larger — about 6.5× TransMedics Group Inc's market cap, and SiTime Corporation is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| SITM | TMDX | |
|---|---|---|
Market Cap | $16.63B | $2.54B |
Sector | Technology | Technology |
52-Week High | $901.60 | $150.42 |
52-Week Low | $190.16 | $61.99 |
Enterprise Value | $15.84B | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SiTime Corporation
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
